| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.17B | 2.22B | 2.25B | 2.25B | 2.17B | 2.09B |
| Gross Profit | 894.30M | 924.90M | 955.70M | 940.80M | 880.50M | 951.20M |
| EBITDA | 150.50M | 185.60M | 285.40M | 317.60M | 285.40M | 302.10M |
| Net Income | -38.20M | 25.40M | 98.60M | 114.70M | 99.50M | 117.80M |
Balance Sheet | ||||||
| Total Assets | 3.77B | 3.76B | 3.73B | 3.74B | 3.71B | 3.67B |
| Cash, Cash Equivalents and Short-Term Investments | 223.30M | 225.70M | 209.10M | 216.40M | 188.70M | 479.20M |
| Total Debt | 1.55B | 1.54B | 1.39B | 1.45B | 1.46B | 1.32B |
| Total Liabilities | 2.28B | 2.20B | 2.15B | 2.20B | 2.25B | 2.09B |
| Stockholders Equity | 1.49B | 1.55B | 1.58B | 1.54B | 1.47B | 1.58B |
Cash Flow | ||||||
| Free Cash Flow | 36.30M | 41.40M | 174.50M | 166.60M | 45.60M | 172.20M |
| Operating Cash Flow | 108.10M | 118.40M | 231.00M | 216.10M | 102.00M | 229.00M |
| Investing Cash Flow | -67.10M | -72.90M | -62.40M | -50.50M | -355.40M | -48.70M |
| Financing Cash Flow | -6.50M | -30.00M | -179.40M | -146.50M | -17.60M | -65.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $24.87B | 34.84 | 17.62% | 1.38% | 1.45% | 42.04% | |
68 Neutral | $1.81B | 18.31 | 5.34% | 3.15% | -5.21% | 1.96% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $36.88B | 18.32 | 147.22% | 5.03% | -10.04% | -23.41% | |
52 Neutral | $1.05B | -26.44 | 1.62% | 3.51% | -1.34% | -73.59% | |
51 Neutral | $2.35B | -4.26 | -14.50% | ― | -5.68% | -358.36% | |
49 Neutral | $1.93B | -6.69 | -11.09% | 7.76% | -5.88% | 90.23% |
At its February 5, 2026 annual meeting, Edgewell shareholders approved the company’s 3rd Amended and Restated 2018 Stock Incentive Plan, adding 2.1 million authorized shares, removing the fungible share ratio for new awards, and updating provisions in light of U.S. tax code changes. Investors also re-elected the full slate of directors, ratified PricewaterhouseCoopers as auditor for fiscal 2026, and backed the advisory vote on executive pay, underscoring broad support for management and its compensation and governance framework.
On February 9, 2026, Edgewell reported first-quarter fiscal 2026 results modestly ahead of its expectations for sales, adjusted EPS and EBITDA and confirmed its full-year outlook for continuing operations after completing the $340 million divestiture of its Feminine Care business. While revenue grew slightly and currency provided a tailwind, margins and earnings remained pressured by inflation, restructuring charges and higher interest costs, even as the company signaled a more focused portfolio and balance-sheet strengthening that it believes position it for sustainable growth and shareholder returns.
The most recent analyst rating on (EPC) stock is a Hold with a $19.00 price target. To see the full list of analyst forecasts on Edgewell Personal Care stock, see the EPC Stock Forecast page.
On February 2, 2026, Edgewell Personal Care completed the previously announced sale of its Feminine Care business to Swedish health and hygiene group Essity for approximately $340 million in cash, transferring specified assets and liabilities under an asset purchase agreement first signed in November 2025. Edgewell plans to use the net proceeds, after taxes and transaction costs, primarily to strengthen its balance sheet by paying down its U.S. revolving credit facility and to continue investing in the long-term growth of its core shave, sun and skin care, and grooming franchises, a shift management describes as a pivotal step in simplifying the portfolio and sharpening strategic focus; the company has also entered a transition services agreement with Essity for at least one year to support accounting, IT, quality, operations, supply chain and sales, and will reclassify the divested unit as a discontinued operation in upcoming pro forma financial disclosures to investors.
The most recent analyst rating on (EPC) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Edgewell Personal Care stock, see the EPC Stock Forecast page.